NCT04479748View on ClinicalTrials.gov

DEXTENZA Compared to Topical Steroid Therapy Prior to Cataract Surgery in Patients Who Receive Premium Intraocular Lenses

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

December 12, 2022

Study Completion Date

December 12, 2022

Conditions

Cataract

Interventions

DRUG

Dexamethasone

Treatment of pain and inflammation following ophthalmic surgery

DRUG

Prednisolone Acetate 1% Oph Susp

Topical steroid

Trial Locations (1)

08361

Eye Associates of Vineland, Vineland

All Listed Sponsors

lead

Prism Vision Group

OTHER

NCT04479748 - DEXTENZA Compared to Topical Steroid Therapy Prior to Cataract Surgery in Patients Who Receive Premium Intraocular Lenses | Biotech Hunter | Biotech Hunter